ABRAXANE Approved by European Commission for First-Line Treatment of Patients with Non-Small Cell Lung Cancer
March 02, 2015 at 09:56 AM EST
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the ...